Methotrexate in Italian patients with Rheumatoid Arthritis (MITRA study): An observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology

F. Benaglio, M. Fornaro, C. Montecucco, B. Raffeiner, M. Di Franco, C. Iannuccelli, P. Conigliaro, C. Lomater, M. Govoni, E. Silvagni, A. Zanetti, S. Parisi, G. Carrara, C. A. Scirè, F. Iannone, R. Caporali

Research output: Contribution to journalArticlepeer-review

Abstract

Objective To assess the delay between the disease onset and the beginning of methotrexate (MTX) treatment in RA patients and to evaluate the Italian rheumatologists adherence to the EULAR 2013 recommendations. Methods MITRA is an Italian multicentre observational study carried out on DMARD-naïve RA patients recruited in an 18-month period starting from 2015. The data related to the patients characteristics at baseline will be presented. Results 332 patients from 13 Italian centres were recruited: The median delay between the onset of symptoms and the beginning of MTX was 197 days (102 431); in 20% of patients a treatment with DMARDs was started within the first 90 days from the onset of symptoms. The clinical target selected was DAS28 remission in 64.2% of cases and low disease activity in 35.8%. Among patients in DAS28 high disease activity, 92.6% received a control visit which was rescheduled within the first 3 months, similarly to those in DAS28 moderate disease activity (91.6%). A DMARD monotherapy was prescribed in 319 patients, while a combined therapy of DMARDs was preferred in 13 cases; 282 patients were treated with MTX. Glucocorticoids were prescribed in 229 patients: The median dosage was of 5 mg (IQR 5 7.5) of prednisone equivalent/day. Conclusion Diagnostic delay in RA patients continues to be longer than expected. The choice of low disease activity as a target is still very frequent and tight control does not seem to be based on disease activity. This paper offers a realistic and detailed picture of the clinical practice among Italian rheumatologists.

Original languageEnglish
Pages (from-to)1077-1084
Number of pages8
JournalClinical and Experimental Rheumatology
Volume39
Issue number5
Publication statusPublished - Sep 2021

Keywords

  • adherence
  • delay
  • EULAR recommendations
  • rheumatoid arthritis
  • treat to target

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Fingerprint

Dive into the research topics of 'Methotrexate in Italian patients with Rheumatoid Arthritis (MITRA study): An observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology'. Together they form a unique fingerprint.

Cite this